s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Monday, March 3, 2025
Accession number
0001193125-25-044183
Documents
POS AM
POS AM
EX-5.1
EX-5.1
EX-23.2
EX-23.2
On sec.gov
Filing index
All files
Complete submission text
SGML header